Associate Professor Andrew Chang

Associate Professor
Andrew Chang

MBBS(Hons), PhD (Syd), FRANZCO, FRACS

Background

Associate Professor Andrew Chang is a Vitreoretinal surgeon and Ophthalmologist. He holds an academic appointment of Clinical Associate Professor at The University of Sydney. He is a consultant ophthalmologist, the Head of Ophthalmology and the Head of the Retinal Unit at the Sydney Eye Hospital. Associate Professor Chang is the Medical Director of Sydney Retina Clinic and Day Surgery. He graduated from The University of Sydney Medical School and trained at the Sydney Eye Hospital with fellowships at Royal Victorian Eye and Ear Hospital and in the United States. He was awarded a PhD for research into retinal and choroidal angiography performed in the Universities of California and Sydney.

Associate Professor Andrew Chang

His commitment to international Ophthalmology includes Secretary General of the Asia-Pacific Vitreoretinal Society (APVRS) and Council Member of the Asia Pacific Academy of Ophthalmology (APAO). He is a clinician advisor to the Department of Health Australia. He serves on the Board of the Sydney Eye Hospital Foundation. Professional awards include the Achievement Award and Distinguished Service Award of the APAO and the RANZCO Excellence in Teaching Award.

Associate Professor Chang is passionately involved in basic science and clinical trials research, receiving research grant funding in Australia and USA. His research is extensively published in peer-reviewed scientific literature. He serves on the editorial boards of scientific peer-reviewed journals. In wider healthcare activities, Associate Professor Chang is engaged in the complexities of modern hospital healthcare delivery. He supports new medical drugs and devices by participating in clinical trials development. He drives strategies aimed at better patient engagement with healthcare professionals using the latest in cloud, IoT and Artificial Intelligence.

Related Publications

Scientific Journal Publications

Spooner KL, Fraser-Bell S, Hong T, Wong JG, Chang AA. Long-term outcomes of anti-VEGF treatment of retinal vein occlusion. Eye (Lond). 2021 Jun 11.

Read more
Scientific Journal Publications

Ogura Y, Jaffe GJ, Cheung CM, Kokame GT, Iida T, Takahashi K, Lee WK, Chang AA, Monés J, D’Souza D, Weissgerber G. Efficacy and safety of brolucizumab versus aflibercept in eyes with polypoidal choroidal vasculopathy in Japanese participants of HAWK. British Journal of Ophthalmology. 2021 Jul 21.

Read more
Scientific Journal Publications

Jhaveri, C., Wykoff, C.C., Khanani, A.M., Eandi, C.M., Chang, A., Guruprasad, B., Gedif, K.A. and Singer, M., 2021. Early Residual Fluid-free Status and Long-term BCVA outcomes: A Treatment Agnostic, Post-hoc Analysis of Pooled HAWK and HARRIER Data. American Journal of Ophthalmology.

Read more
Scientific Journal Publications

Racic T, Chang A, Fernando N, Brandli A, Natoli R, Penfold P, Provis JM, Rutar M. Anti-inflammatory and neuroprotective properties of the corticosteroid fludrocortisone in retinal degeneration. Exp Eye Res. 2021 Sep 9:108765. doi: 10.1016/j.exer.2021.108765. Epub ahead of print. PMID: 34509498.

Read more

Our Affiliates